ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this pill stop Alzheimer's before it starts? new trial targets High-Risk gene carriers
Prevention Not yet recruitingThis study tests an experimental drug, HT-4253, to see if it can lower the risk of developing Alzheimer's disease in people who carry the APOE4 gene and have early signs of brain changes. About 112 participants aged 50-75 will receive either the drug or a placebo for 48 weeks. Th…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated May 15, 2026 11:56 UTC
-
New hope for Alzheimer's: drug combo safety trial launches
Symptom relief Not yet recruitingThis study tests whether adding an experimental drug (X/T+X-EC) to the existing Alzheimer's medication lecanemab is safe and tolerable. About 60 people with Alzheimer's will receive either the new drug or a placebo for 24 weeks. The main goal is to check for side effects, not to …
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Symptom relief
Last updated May 05, 2026 11:55 UTC